Sue Siegel is CEO of GE Ventures and of Healthymagination, GE’s innovation platform for addressing quality, access, and affordability of health care. With 30-plus years’ experience in corporations and venture capital, she was previously a general partner at Mohr Davidow Ventures and president of Affymetrix. Currently serving on numerous boards, Siegel was on the working group for President Obama’s Precision Medicine Initiative and an inaugural board member for the NIH’s National Center for Advancing Translation Sciences. Named one of the most influential women in Silicon Valley, she is an Aspen Institute Henry Crown Fellow and member of the National Academies of Sciences-Medicine’s President’s Circle, YPO-Gold, and Women Corporate Directors.